Literature DB >> 1848480

Histochemical profile of mouse hepatocellular adenomas and carcinomas induced by a single dose of diethylnitrosamine.

H J Hacker1, H Mtiro, P Bannasch, S D Vesselinovitch.   

Abstract

In continuation of earlier studies on murine neoplastic liver lesions, we characterized by histochemical methods the phenotype of hepatocellular adenomas and carcinomas induced by single injections of diethylnitrosamine (1.25, 2.5, or 5.0 micrograms/g of body weight) in 15-day-old C57BL/6 x male C3H F1 mice. The hepatocellular adenomas were composed predominantly of basophilic cells but stored excessive amounts of fat and glycogen in large portions of the tumors. Irrespective of the carcinogenic dose, the adenomas showed a consistent histochemical pattern. Glycogen synthase and phosphorylase were highly active in the hepatocytes that stored glycogen. In cells poor in, or free of, this polysaccharide, these enzymes were only moderately active or even inactive. In glycogen-storing parts of the adenomas, the activity of adenylate cyclase was reduced compared with normal liver parenchyma, but in fat-storing portions it was elevated. In a few adenomas, uniform increase in adenylate cyclase activity could be encountered. The levels of ATPase, acid phosphatase, and glucose-6-phosphatase were either increased or decreased. Glucose-6-phosphate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase showed an increased activity in all adenomas compared with preneoplastic foci, which in turn exhibited a higher glucose-6-phosphate dehydrogenase and glyceraldehyde-3-phosphate dehydrogenase activity than the surrounding parenchyma or the liver of untreated controls. The hepatocellular carcinomas showed remarkable histochemical changes compared with adenomas. The levels of fat and glycogen and the activities of glycogen synthase, phosphorylase, and in most cases also that of glucose-6-phosphate dehydrogenase, were reduced significantly. In contrast, adenylate cyclase, glucose-6-phosphatase, glyceraldehyde-3-phosphate dehydrogenase, and also alkaline phosphatase showed a striking elevation in developing carcinomas. Similar, although more pronounced, histochemical changes were seen in the advanced hepatocellular carcinomas. These observations indicated that progression from adenomas to hepatocellular carcinomas was associated with a change in the activity of several enzymes involved in cell membrane function, glycogen metabolism, the oxidative pentose phosphate pathway, and glycolysis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1848480

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

1.  Neonatal streptozotocin treatment causes type 1 diabetes and subsequent hepatocellular carcinoma in DIAR mice fed a normal diet.

Authors:  Hayato Baba; Koichi Tsuneyama; Takeshi Nishida; Hideki Hatta; Takahiko Nakajima; Kazuhiro Nomoto; Shinichi Hayashi; Shigeharu Miwa; Yuko Nakanishi; Ryoji Hokao; Johji Imura
Journal:  Hepatol Int       Date:  2014-06-20       Impact factor: 6.047

2.  Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma.

Authors:  Femke Heindryckx; Koen Mertens; Nicolas Charette; Bert Vandeghinste; Christophe Casteleyn; Christophe Van Steenkiste; Dominique Slaets; Louis Libbrecht; Steven Staelens; Peter Starkel; Anja Geerts; Isabelle Colle; Hans Van Vlierberghe
Journal:  Mol Cancer       Date:  2010-08-20       Impact factor: 27.401

Review 3.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

4.  Caspase-2 deficiency accelerates chemically induced liver cancer in mice.

Authors:  S Shalini; A Nikolic; C H Wilson; J Puccini; N Sladojevic; J Finnie; L Dorstyn; S Kumar
Journal:  Cell Death Differ       Date:  2016-08-12       Impact factor: 15.828

Review 5.  Animal Models: A Useful Tool to Unveil Metabolic Changes in Hepatocellular Carcinoma.

Authors:  Marina Serra; Amedeo Columbano; Andrea Perra; Marta Anna Kowalik
Journal:  Cancers (Basel)       Date:  2020-11-10       Impact factor: 6.639

6.  Suppression by oestrogen of hepatocellular tumourigenesis induced in mice by 3'-methyl-4-dimethylaminoazobenzene.

Authors:  R Yamamoto; M Tatsuta; N Terada
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

7.  Assessment of hemodynamics in a rat model of liver cirrhosis with precancerous lesions using multislice spiral CT perfusion imaging.

Authors:  Guolin Ma; Rongjie Bai; Huijie Jiang; Xuejia Hao; Zaisheng Ling; Kefeng Li
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

Review 8.  Mouse models of liver cancer: Progress and recommendations.

Authors:  Li He; De-An Tian; Pei-Yuan Li; Xing-Xing He
Journal:  Oncotarget       Date:  2015-09-15

9.  A method to establish a c-Myc transgenic mouse model of hepatocellular carcinoma.

Authors:  Yan Mei; Chao Zhou; Chao-Yong Liang; Guan-Ming Lu; Mu-Sheng Zeng; Jin-Jin Wang; Guo-Kai Feng
Journal:  MethodsX       Date:  2020-05-17

10.  A Modified Protocol of Diethylnitrosamine Administration in Mice to Model Hepatocellular Carcinoma.

Authors:  Azra Memon; Yuliya Pyao; Yerin Jung; Jung Il Lee; Woon Kyu Lee
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.